Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Allison Rogich
Expression of a Recombinant High Affinity IgG Fc Receptor by Engineered NK Cells as a Docking Platform for Therapeutic mAbs to Target Cancer Cells
Frontiers in Immunology
Allergy
Immunology
Related publications
Natural Killer (NK) Cells Engineered to Target Tumors
Science-Business eXchange
High-Affinity CD16-polymorphism and Fc-Engineered Antibodies Enable Activity of CD16-chimeric Antigen Receptor-Modified T Cells for Cancer Therapy
British Journal of Cancer
Cancer Research
Oncology
Validation of TPX2 as a Potential Therapeutic Target in Pancreatic Cancer Cells
Clinical Cancer Research
Cancer Research
Oncology
Glioblastoma Stem Cells as a New Therapeutic Target for Glioblastoma
Clinical Medicine Insights: Oncology
Oncology
miR-133 Regulates Evi1 Expression in AML Cells as a Potential Therapeutic Target
Scientific Reports
Multidisciplinary
Cancer Stem Cells (CSCs) as a Rational Therapeutic Cancer Target, and Screening for CSC-targeting Drugs
Yakugaku Zasshi
Pharmacology
Pharmaceutical Science
Engineered Red Blood Cells as Therapeutic Agents
American Journal of Hematology
Hematology
Evolutionary Story of the Low/Medium-Affinity IgG Fc Receptor Gene Cluster
Frontiers in Immunology
Allergy
Immunology
Dynamics of the Interaction of Human IgG Subtype Immune Complexes With Cells Expressing R and H Allelic Forms of a Low-Affinity Fc Receptor CD32A
Journal of Immunology
Allergy
Immunology